Midgard

EirGenix

New Taipei City, Taiwan eirgenix.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

EirGenix is a biologics CDMO and biosimilar developer that serves biopharmaceutical clients. It operates cGMP manufacturing facilities in Xizhi, New Taipei City and Zhubei, Hsinchu County, Taiwan.

Services

  • Cell Line Development

    Develops expression vectors and stable producer cell lines for downstream process development and manufacturing.

    Cell line development

  • Process Development

    Provides end-to-end development and analytical testing support for biopharmaceuticals from pre-clinical to commercial scale.

  • Analytical & Quality Control

    Offers analytical services, method development, validation, and transfer to quality control for GMP production.

  • cGMP Manufacturing - Mammalian System

    Provides contract development and manufacturing services for biologics in mammalian systems from pre-clinical to commercial scale.

  • cGMP Manufacturing - Microbial System

    Provides contract development and manufacturing services for microbial-derived biologics from pre-clinical to commercial stages.

  • ADC & Bioconjugates

    Develops and manufactures antibody-drug conjugates and other conjugates, including non-cytotoxic conjugates.

  • Commercial / Market-Available Products

    Markets EG12014, a trastuzumab biosimilar sold as EIRGASUN® and HERWENDA® in different markets.

  • Supporting Products & Platforms

    Supplies CRM197 carrier protein and HRV3C protease in GMP-grade and R&D-grade formats.

Capabilities

Assays and studies
  • ADCs
  • Process development
  • Antibodies
  • Bioreactors
  • Analytical development
  • Analytical testing
9 more
  • Analytical method development
  • Method validation
  • Quality control testing
  • Method transfer
  • Method qualification
  • Raw material testing
  • In-process testing
  • Lot release testing
  • Stability testing
Scale and capacity
  • Pre-clinical scale
  • Pilot-scale
  • Late-stage clinical scale
  • Commercial scale
  • 200 L-2,000 L single-use bioreactors
  • 20 L-1,500 L microbial fermentation systems
  • Preclinical and pilot-scale mammalian manufacturing
  • Late-stage clinical and commercial-scale mammalian manufacturing
Therapeutic areas
  • Biopharmaceuticals
  • Breast cancer
  • Conjugate vaccines

Modalities and species

Modalities
  • Antibody
  • ADC
  • Recombinant protein
  • Vaccine
  • Biosimilar
  • Plasmid DNA
Species and models
  • Mammalian cells
  • Microbial systems
  • Mammalian cell culture
  • Microbial fermentation

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: manufacturing facilities and services

Industries served

  • Biopharmaceuticals
  • Biotech

Details

Type
CRDMO
Founded
2012
Based in
New Taipei City, Taiwan
Sites
  • Xizhi, New Taipei City, Taiwan
  • Zhubei, Hsinchu County, Taiwan
Serves
Global, 15+ countries

Similar labs